BankInvest, the Danish asset management house, has invested in Ark Therapeutics, the Anglo-Finnish biotechnology company which raised a total of £14.5m (€23m) in its third round of fundraising.

BankInvest led the financing round alongside investors that include Merlin Biosciences and Nomura International.

Yasmine Chinwala

Evelyn Partners professional services arm to rebrand after Apax sale

Private equity giants and law firms bet big on Milan amid hot M&A market

Evelyn Partners sells accounting arm to Apax for £700m

Proskauer Rose hires John Goldfinch after A&O Shearman drink-driving exit

https://images.fnlondon.com/im-50640110?size=1.5

US law firm adds finance partner after A&O Shearman departure

Trading Places: Goldman’s ECM shake-up, Latham’s latest raid

https://images.fnlondon.com/im-329118?size=1.5

Find out who is on the move in the City and beyond this week

Sidley Austin raids Latham & Watkins for 10-lawyer team in London

https://images.fnlondon.com/im-38645354?size=1.5

Internal company documents describe the bank’s weak anti-money-laundering controls and failure to complete due-diligence reviews as staff expressed alarm: “We need to kill this.”

How Morgan Stanley Courted Dodgy Customers to Build a Wealth-Management Empire

Brokerages seeking to meet the growing global appetite for U.S. stocks are extending their timetables.

Welcome to the World of 24-Hour Stock Trading

Donald Trump’s pick for Treasury secretary has been a fierce defender of his activist approach to trade.

Scott Bessent Sees a Coming ‘Global Economic Reordering.’ He Wants to Be Part of It.

Green industrial policy is failing in Europe, a warning to the next Trump Administration.

Northvolt’s Bankruptcy and the EV Crash

Atos has received a non-binding offer from the French government to acquire its advanced computing activities for an enterprise value of around $521 million.

Atos Jumps on French State Bid for Advanced Computing Business

Atos Shares Jump on French State Bid for Advanced Computing Business

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

https://www.wsj.com/?type=allesseh_content_full_list

https://www.fnlondon.com/client

MY ACCOUNT

ABOUT

SECTIONS

unbolded

BankInvest invests in Ark Therapeutics

Financial News